{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:29:27Z","timestamp":1754144967055,"version":"3.41.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,16]]},"DOI":"10.7759\/cureus.88049","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T07:50:28Z","timestamp":1752652228000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Refractory Methicillin-Sensitive Staphylococcus aureus Osteomyelitis With Ceftaroline Fosamil in a Diabetic Patient"],"prefix":"10.7759","author":[{"given":"Sarah","family":"Baroud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Alhammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Alhashimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Elhaout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasanain","family":"Al-Shakerchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3791-z","article-title":"Use of ceftaroline fosamil in osteomyelitis: CAPTURE study experience","volume":"19","author":"Johnson LB","year":"2019","unstructured":"Johnson LB, Ramani A, Guervil DJ. Use of ceftaroline fosamil in osteomyelitis: CAPTURE study experience. BMC Infect Dis. 2019, 19:183. 10.1186\/s12879-019-3791-z","journal-title":"BMC Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2022.09.017","article-title":"The golden grapes of wrath - Staphylococcus aureus bacteremia: a clinical review","volume":"136","author":"Lam JC","year":"2023","unstructured":"Lam JC, Stokes W. The golden grapes of wrath - Staphylococcus aureus bacteremia: a clinical review. Am J Med. 2023, 136:19-26. 10.1016\/j.amjmed.2022.09.017","journal-title":"Am J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.8.3.244","article-title":"Bacteremia in diabetic patients: comparison of incidence and mortality with nondiabetic patients","volume":"8","author":"Bryan CS","year":"1985","unstructured":"Bryan CS, Reynolds KL, Metzger WT. Bacteremia in diabetic patients: comparison of incidence and mortality with nondiabetic patients. Diabetes Care. 1985, 8:244-9. 10.2337\/diacare.8.3.244","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-013-0010-x","article-title":"Ceftaroline fosamil: a brief clinical review","volume":"2","author":"Shirley DA","year":"2013","unstructured":"Shirley DA, Heil EL, Johnson JK. Ceftaroline fosamil: a brief clinical review. Infect Dis Ther. 2013, 2:95-110. 10.1007\/s40121-013-0010-x","journal-title":"Infect Dis Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2017.1351729","article-title":"Ceftaroline for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus: a case series","volume":"30","author":"Lalikian K","year":"2018","unstructured":"Lalikian K, Parsiani R, Won R, Chang E, Turner RB. Ceftaroline for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus: a case series. J Chemother. 2018, 30:124-8. 10.1080\/1120009X.2017.1351729","journal-title":"J Chemother"},{"key":"ref6","article-title":"Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia","volume":"82","author":"Obed MN","year":"2022","unstructured":"Obed MN, Toresani I, Mykietuk A, Nannini EC. Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia. Medicina (B Aires). 2022, 82:794-7.","journal-title":"Medicina (B Aires)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline","volume":"36","author":"Sakoulas G","year":"2014","unstructured":"Sakoulas G, Moise PA, Casapao AM, et al.. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline. Clin Ther. 2014, 36:1317-33. 10.1016\/j.clinthera.2014.05.061","journal-title":"Clin Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac129","article-title":"Successful use of nafcillin and ceftaroline combination therapy for persistent MSSA bacteraemia and endocarditis: a case series","volume":"5","author":"Warren EF","year":"2023","unstructured":"Warren EF, Crocker RJ, Tabor B, et al.. Successful use of nafcillin and ceftaroline combination therapy for persistent MSSA bacteraemia and endocarditis: a case series. JAC Antimicrob Resist. 2023, 5:dlac129. 10.1093\/jacamr\/dlac129","journal-title":"JAC Antimicrob Resist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0075-6","article-title":"Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia","volume":"73","author":"Frampton JE","year":"2013","unstructured":"Frampton JE. Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia. Drugs. 2013, 73:1067-94. 10.1007\/s40265-013-0075-6","journal-title":"Drugs"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/10600280221082326","article-title":"Ceftaroline: systematic review of clinical uses and emerging drug resistance","volume":"56","author":"Abate G","year":"2022","unstructured":"Abate G, Wang G, Frisby J. Ceftaroline: systematic review of clinical uses and emerging drug resistance. Ann Pharmacother. 2022, 56:1339-48. 10.1177\/10600280221082326","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/379768-successful-treatment-of-refractory-methicillin-sensitive-staphylococcus-aureus-osteomyelitis-with-ceftaroline-fosamil-in-a-diabetic-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T07:50:28Z","timestamp":1752652228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/379768-successful-treatment-of-refractory-methicillin-sensitive-staphylococcus-aureus-osteomyelitis-with-ceftaroline-fosamil-in-a-diabetic-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.88049","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}